Metropolitan Life Insurance Company (MetLife)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-900	Closed	-$49.5K	–	2402
2022 Q2	$49.5K	Buy	+900	New	+$47.2K	﹤0.01%	1521

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SRRA Position: Q3 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 900 shares — an estimated $49.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $49.5K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 900 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $49.5K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s Sierra Oncology, Inc. Common Stock position peaked at $49.5K in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.